Effective Date: 2026-11-21 | Governing Law: State of Delaware
This Mutual Non-Disclosure Agreement ("Agreement") is entered into as of 2026-11-21 ("Effective Date") by and between Lumen Labs, Inc., located at 548 Market St, San Francisco, CA 94104 and Crestline Ventures LLC, located at 101 California St, San Francisco, CA 94111 (each a "Party" and collectively the "Parties"). In connection with exploring a potential strategic partnership, product integration, or commercial relationship (the "Purpose"), each Party may disclose certain non-public, confidential, or proprietary information to the other Party.
"Confidential Information" means any non-public technical, financial, product, customer, pricing, source code, roadmap, or business information disclosed orally, visually, or in writing by either Party ("Disclosing Party") to the other Party ("Receiving Party") that is designated as confidential or that reasonably should be understood to be confidential given its nature and the circumstances of disclosure.
Receiving Party agrees to: (a) hold Confidential Information in strict confidence using at least the same degree of care it uses to protect its own confidential information, and in no event less than reasonable care; (b) use Confidential Information solely for the Purpose; and (c) restrict disclosure to its employees, officers, advisors, or contractors who have a strict need to know and are bound by written confidentiality obligations at least as protective as this Agreement.
Confidential Information does not include information that Receiving Party can document: (a) is or becomes generally available to the public without breach of this Agreement; (b) was lawfully known to Receiving Party prior to disclosure; (c) is independently developed without use of or reference to Confidential Information; or (d) is rightfully received from a third party without confidentiality restrictions. If disclosure is compelled by law or court order, Receiving Party will provide prompt prior written notice (where legally permitted) to allow Disclosing Party to seek protective relief.
The confidentiality obligations under this Agreement shall remain in effect for 3 (3) years from the Effective Date, and for so long as any trade secret retains trade-secret protection under applicable law.
Upon written request of Disclosing Party or termination of discussions regarding the Purpose, Receiving Party shall promptly return or securely destroy all tangible and electronic copies of Confidential Information and, upon request, certify such destruction in writing (excluding routine automated archival backups retained under standard IT retention policies, which remain subject to this Agreement).
All Confidential Information remains the sole property of Disclosing Party. Nothing in this Agreement grants any license, ownership, or intellectual property rights to Receiving Party, nor obligates either Party to enter into any further business transaction or definitive agreement.
Receiving Party acknowledges that unauthorized disclosure or misuse of Confidential Information may cause irreparable harm for which monetary damages alone may be inadequate, and Disclosing Party shall be entitled to seek equitable and injunctive relief in addition to all other remedies available at law.
This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to conflict-of-laws principles. This document constitutes the entire agreement between the Parties regarding the subject matter hereof and may only be amended in a writing signed by both Parties. Electronic signatures and counterparts shall have the same legal effect as original ink signatures.
Lumen Labs, Inc.
Samira Patel, Chief Executive Officer
Crestline Ventures LLC
Daniel Brooks, Partner